Cargando…
Disseminated Infections with Talaromyces marneffei in Non-AIDS Patients Given Monoclonal Antibodies against CD20 and Kinase Inhibitors
Clinicians should be aware of these infections, especially in patients from disease-endemic regions.
Autores principales: | Chan, Jasper F.W., Chan, Thomas S.Y., Gill, Harinder, Lam, Frank Y.F., Trendell-Smith, Nigel J., Sridhar, Siddharth, Tse, Herman, Lau, Susanna K.P., Hung, Ivan F.N., Yuen, Kwok-Yung, Woo, Patrick C.Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816330/ https://www.ncbi.nlm.nih.gov/pubmed/26079984 http://dx.doi.org/10.3201/eid2107.150138 |
Ejemplares similares
-
Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients
por: Chan, Jasper FW, et al.
Publicado: (2016) -
Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
por: Sridhar, Siddharth, et al.
Publicado: (2019) -
Talaromyces marneffei
por: Mahajan, Monika
Publicado: (2021) -
Disseminated Talaromyces marneffei in newly diagnosed HIV patient
por: Huang, Yingcai, et al.
Publicado: (2022) -
Anti–IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections
por: Guo, Jing, et al.
Publicado: (2020)